Tech Company Financing Transactions
Cardialen Funding Round
On 10/11/2018, Cardialen raised $17 million in Series B funding from RiverVest Venture Partners, Cultivation Capital and HBM Healthcare Investments.
Transaction Overview
Company Name
Announced On
10/11/2018
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Series B
Investors
RiverVest Venture Partners (Lead Investor) (Jay Schmelter)
Proceeds Purpose
The financing will be used to advance Cardialen's clinical program with further human testing of its unpinning termination (UPT) therapy and begin development of an implantable device.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6160 Summit Drive N. 450
Minneapolis, MN 55430
USA
Minneapolis, MN 55430
USA
Phone
Website
Email Address
Not Recorded
Overview
Cardialen is revolutionizing atrial fibrillation (AF) treatment by offering a unique solution: a gentle, low energy therapy, released from an implantable device. This treatment will stop symptoms at the onset of AF, keep people out of the healthcare system, and greatly reduce AF's significant financial impact.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Peters
Chief Financial Officer
John Testa
Vice President
Thomas Rasmussen
VP - Regulatory Affairs
Michelle Straight
Browse more venture capital transactions:
Prev: 10/11/2018: My Ally venture capital transaction
Next: 10/11/2018: Cnex Labs venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs